These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37630200)

  • 21. Therapeutic Targeting of TLR4 for Inflammation, Infection, and Cancer: A Perspective for Disaccharide Lipid A Mimetics.
    Heine H; Zamyatina A
    Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
    Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
    Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica.
    Hajjar AM; Ernst RK; Fortuno ES; Brasfield AS; Yam CS; Newlon LA; Kollmann TR; Miller SI; Wilson CB
    PLoS Pathog; 2012; 8(10):e1002963. PubMed ID: 23071439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide.
    Lien E; Means TK; Heine H; Yoshimura A; Kusumoto S; Fukase K; Fenton MJ; Oikawa M; Qureshi N; Monks B; Finberg RW; Ingalls RR; Golenbock DT
    J Clin Invest; 2000 Feb; 105(4):497-504. PubMed ID: 10683379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonreducing Sugar Scaffold Enables the Development of Immunomodulatory TLR4-specific LPS Mimetics with Picomolar Potency.
    Strobl S; Zucchetta D; Vašíček T; Monti A; Ruda A; Widmalm G; Heine H; Zamyatina A
    Angew Chem Int Ed Engl; 2024 Sep; 63(39):e202408421. PubMed ID: 38870340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.
    Zusso M; Lunardi V; Franceschini D; Pagetta A; Lo R; Stifani S; Frigo AC; Giusti P; Moro S
    J Neuroinflammation; 2019 Jul; 16(1):148. PubMed ID: 31319868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of αGlcN(1↔1)αMan-based lipid A mimetics as a novel class of potent Toll-like receptor 4 agonists.
    Adanitsch F; Ittig S; Stöckl J; Oblak A; Haegman M; Jerala R; Beyaert R; Kosma P; Zamyatina A
    J Med Chem; 2014 Oct; 57(19):8056-71. PubMed ID: 25252784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ability of supragingival plaque to induce toll-like receptor 4-mediated stimulation is associated with cytokine production by peripheral blood mononuclear cells.
    Yamaguchi R; Yoshimura A; Yoshioka H; Kaneko T; Hara Y
    J Periodontol; 2009 Mar; 80(3):512-20. PubMed ID: 19254136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of soluble MD-1 and its interaction with lipid IVa.
    Yoon SI; Hong M; Han GW; Wilson IA
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10990-5. PubMed ID: 20534476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoteichoic Acid Inhibits Lipopolysaccharide-Induced TLR4 Signaling by Forming an Inactive TLR4/MD-2 Complex Dimer.
    Watanabe S; Zenke K; Muroi M
    J Immunol; 2023 May; 210(9):1386-1395. PubMed ID: 36897262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disaccharide-Based Anionic Amphiphiles as Potent Inhibitors of Lipopolysaccharide-Induced Inflammation.
    Borio A; Holgado A; Garate JA; Beyaert R; Heine H; Zamyatina A
    ChemMedChem; 2018 Nov; 13(21):2317-2331. PubMed ID: 30276970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than that with MD-2 or CD14.
    Akashi S; Saitoh S; Wakabayashi Y; Kikuchi T; Takamura N; Nagai Y; Kusumoto Y; Fukase K; Kusumoto S; Adachi Y; Kosugi A; Miyake K
    J Exp Med; 2003 Oct; 198(7):1035-42. PubMed ID: 14517279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa.
    Muroi M; Tanamoto K
    J Biol Chem; 2006 Mar; 281(9):5484-91. PubMed ID: 16407172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MD-2-mediated ionic interactions between lipid A and TLR4 are essential for receptor activation.
    Meng J; Lien E; Golenbock DT
    J Biol Chem; 2010 Mar; 285(12):8695-702. PubMed ID: 20018893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.
    Barata TS; Teo I; Brocchini S; Zloh M; Shaunak S
    PLoS Comput Biol; 2011 Jun; 7(6):e1002095. PubMed ID: 21738462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species and mediator specific TLR4 antagonism in primary human and murine immune cells by βGlcN(1↔1)αGlc based lipid A mimetics.
    Chebrolu C; Artner D; Sigmund AM; Buer J; Zamyatina A; Kirschning CJ
    Mol Immunol; 2015 Oct; 67(2 Pt B):636-41. PubMed ID: 26319313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties.
    Ciaramelli C; Calabrese V; Sestito SE; Pérez-Regidor L; Klett J; Oblak A; Jerala R; Piazza M; Martín-Santamaría S; Peri F
    Chem Biol Drug Des; 2016 Aug; 88(2):217-29. PubMed ID: 26896420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional mapping of differential amino acids of human, murine, canine and equine TLR4/MD-2 receptor complexes conferring endotoxic activation by lipid A, antagonism by Eritoran and species-dependent activities of Lipid IVA in the mammalian LPS sensor system.
    Scior T; Lozano-Aponte J; Figueroa-Vazquez V; Yunes-Rojas JA; Zähringer U; Alexander C
    Comput Struct Biotechnol J; 2013; 7():e201305003. PubMed ID: 24688739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.